Page last updated: 2024-10-28

ibuprofen and Lung Diseases, Interstitial

ibuprofen has been researched along with Lung Diseases, Interstitial in 1 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research Excerpts

ExcerptRelevanceReference
"We report the case of hypoxic interstitial pneumonitis with eosinophilic alveolitis induced by ibuprofen."1.34[Diffuse interstitial pneumonitis with acute respiratory failure]. ( Daoud, K; François, T; Gounant, V; Milleron, B; Prigent, H, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daoud, K1
Gounant, V1
Prigent, H1
François, T1
Milleron, B1

Other Studies

1 other study available for ibuprofen and Lung Diseases, Interstitial

ArticleYear
[Diffuse interstitial pneumonitis with acute respiratory failure].
    Revue de pneumologie clinique, 2007, Volume: 63, Issue:3

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Bronchoscopy; Female; Humans; Ibuprof

2007